Lichen planus, a chronic autoimmune, mucocutaneous disease affects the oral mucosa (oral
lichen planus or OLP) besides the skin, genital mucosa, scalp and nails. An immune …

Several therapeutic agents have been investigated for the treatment of oral lichen planus
(OLP). Among these are corticosteroids, retinoids, cyclosporine, and phototherapy, in …

B cells may be implicated in the pathophysiology of chronic graft-versus-host disease
(GVHD), as evidenced by antibody production against sex-mismatched, Y chromosome …

Adverse reactions to medications are common and may have a variety of clinical
presentations in the oral cavity. Targeted therapies and the new biologic agents have …

Oral lichen planus (OLP) has a prevalence of approximately 1%. The etiopathogenesis is
poorly understood. The annual malignant transformation is less than 0.5%. There are no …

Oral lichen planus (OLP) is a chronic mucocutaneous condition that affects up to 2% of the
general population, and typically presents with long-standing, non-responsive lesions, with …

The biodiversity of the mycobiome, an important component of the oral microbial community,
and the roles of fungal–bacterial and fungal–immune system interactions in the …

Abstract Background and Objective: Treatment of oral lichen planus (OLP) remains a great
challenge for clinicians. The aim of our study was to compare the effect of low intensity laser …

Oral lichen planus (OLP) and oral lichenoid lesions (OLL) are clinically and histologically
similar lesions but their treatment planning and prognosis are different. The review of the …

Objective In this study, the effect of photodynamic therapy with topical corticosteroid in oral
lichen planus patients was compared. Material and Methods In this randomized, double …